We are live on ! Find out more
CP

Covenant Partners Portfolio holdings

AUM $342M
1-Year Est. Return 19.24%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$13.8M
Cap. Flow
-$371K
Cap. Flow %
-0.14%
Top 10 Hldgs %
49.35%
Holding
208
New
7
Increased
11
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$930K
2
UL icon
Unilever
UL
+$381K
3
EFG icon
iShares MSCI EAFE Growth ETF
EFG
+$367K
4
DXCM icon
DexCom
DXCM
+$322K
5
FND icon
Floor & Decor
FND
+$290K

Top Sells

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$487K
2
VZ icon
Verizon
VZ
+$317K
3
SPLK
Splunk Inc
SPLK
+$314K
4
NVS icon
Novartis
NVS
+$292K
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$231K

Sector Composition

Rank Sector Weight
1 Technology 17.39%
2 Healthcare 8.06%
3 Financials 7.83%
4 Consumer Discretionary 6.21%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPWR icon
126
Monolithic Power Systems
MPWR
$65.5B
$446K 0.17%
1,195
– –
GPN icon
127
Global Payments
GPN
$22.1B
$444K 0.17%
2,368
– –
DRI icon
128
Darden Restaurants
DRI
$22.5B
$440K 0.17%
3,013
– –
TXN icon
129
Texas Instruments
TXN
$255B
$437K 0.16%
2,271
– –
CMCSA icon
130
Comcast
CMCSA
$79.1B
$436K 0.16%
7,639
– –
TAK icon
131
Takeda Pharmaceutical
TAK
$55.1B
$432K 0.16%
25,661
-28,637
-53% -$487K
XLNX
132
DELISTED
Xilinx Inc
XLNX
$432K 0.16%
2,988
– –
ON icon
133
ON Semiconductor
ON
$33.8B
$430K 0.16%
11,233
– –
KEYS icon
134
Keysight
KEYS
$54.5B
$419K 0.16%
2,716
– –
BP icon
135
BP
BP
$113B
$415K 0.16%
15,710
– –
LH icon
136
Labcorp
LH
$24.3B
$411K 0.16%
1,736
– –
BURL icon
137
Burlington
BURL
$22B
$408K 0.15%
1,267
– –
TJX icon
138
TJX Companies
TJX
$170B
$401K 0.15%
5,955
– –
FRC
139
DELISTED
First Republic Bank
FRC
$400K 0.15%
2,136
– –
ALB icon
140
Albemarle
ALB
$13.5B
$393K 0.15%
2,332
– –
COST icon
141
Costco
COST
$415B
$383K 0.14%
967
– –
LII icon
142
Lennox International
LII
$18.8B
$383K 0.14%
1,093
– –
PGR icon
143
Progressive
PGR
$124B
$381K 0.14%
3,879
-57
-1% -$5.64K
STL
144
DELISTED
Sterling Bancorp
STL
$381K 0.14%
15,361
-3,640
-19% -$91.7K
UL icon
145
Unilever
UL
$131B
$377K 0.14%
+5,724
New +$381K
IVV icon
146
iShares Core S&P 500 ETF
IVV
$876B
$376K 0.14%
875
– –
SMG icon
147
ScottsMiracle-Gro
SMG
$4.03B
$376K 0.14%
1,958
– –
CMI icon
148
Cummins
CMI
$91.7B
$375K 0.14%
1,539
– –
PAYC icon
149
Paycom
PAYC
$6.78B
$368K 0.14%
1,013
– –
IVW icon
150
iShares S&P 500 Growth ETF
IVW
$72.5B
$365K 0.14%
5,016
-162
-3% -$11.2K
4 5
6
7 8

Similar funds

SHFA
SS&H Financial Advisors Troy, Michigan $343M AUM 28.43% 1-Year Est. Return
YCG
Yeomans Consulting Group Marietta, Georgia $341M AUM 22.92% 1-Year Est. Return
TAM
Tucker Asset Management Littleton, Colorado $343M AUM 17.55% 1-Year Est. Return
LODC
Lanham O'Dell & Company Hurricane, West Virginia $347M AUM 20.92% 1-Year Est. Return
OFS
Oldfather Financial Services Kearney, Nebraska $336M AUM 15.03% 1-Year Est. Return
MWM
MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return
PPH
Pure Portfolios Holdings Lake Oswego, Oregon $332M AUM 20.54% 1-Year Est. Return
TPW
Transatlantique Private Wealth New York $319M AUM 22.93% 1-Year Est. Return

Covenant Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Covenant Partners held 208 positions worth $265M, up 5.5% from $251M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Covenant Partners's Q2 2021 filing shows 7 new, 11 increased, 28 reduced and 7 closed positions. Its largest new stake was Unilever: 5,724 shares worth $377K. The largest sale was Takeda Pharmaceutical, an estimated $487K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Covenant Partners's largest Q2 2021 buy was Unilever: 5,724 shares worth $377K.
  • Covenant Partners added most to iShares MSCI EAFE Value ETF in Q2 2021, an estimated $930K increase.
  • Covenant Partners's biggest Q2 2021 reduction was Takeda Pharmaceutical, cutting an estimated $487K.
  • Covenant Partners fully exited BioMarin Pharmaceuticals in Q2 2021, selling an estimated $231K.
  • Covenant Partners's ten largest holdings make up 49% of its $265M portfolio in Q2 2021.
  • Covenant Partners opened 7 new positions and closed 7 in Q2 2021.
  • Covenant Partners's portfolio value rose 5.5% quarter-over-quarter to $265M.

Based on Covenant Partners's 13F filing for Q2 2021, filed 2 Aug 2021.